EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series

Jessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, Rusul Al-Marayaty, Nourhane Al Akoum, Himaly Shinglot, Weiqing Jing, Valeria Vizcaino, Borislav A Alexiev, Lee D Cranmer, Elizabeth T Loggers, Hannah Abrams und 10 weitere

Frontiers in Oncology · 20.05.2026 · 16

DOI: 10.3389/fonc.2026.1829331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 20.05.2026. Verfasst von Jessica S Zhang und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metastatic soft tissue sarcomas (STSs) are a heterogeneous group of rare mesenchymal tumors whose treatment options are limited. Our group has been interested in utilizing the synthetic toll-like receptor 4 (TLR4) agonist, glycopyranosyl lipid A in stable-emulsion formulation (GLA-SE), in patients with advanced STSs. Here, we report a case series of three patients with metastatic leiomyosarcoma who had superficial lesions amenable to intratumoral (IT) injection. We explored the safety, tolerability, and immunologic effects of IT GLA-SE given at 20 μg weekly for 12 weeks, both alone and in combination with radiotherapy. In this small case series, treatment was well tolerated, with no serious adverse events observed. Clinically, although no patient had significant tumor shrinkage, two had notable stability in their target lesions despite systemic disease progression. Immunologically, IT GLA-SE induced a clonal expansion of T cells intratumorally in one patient and in peripheral blood in another, suggesting an antitumor effect both at the site of injection and systemically. Moreover, GLA-SE elicited clonal expansion of systemic T cells targeting a well-known immunogenic cancer antigen, NY-ESO-1. The augmented expression of T cells targeting NY-ESO-1 in the systemic circulation of our patient following IT-GLA-SE warrants further investigation, given the promising role of NY-ESO-1 in current and future T-cell based immunotherapies. Together, these findings demonstrate the potential of IT GLA-SE to elicit antigen-specific T cell clonal expansion as a component of immunotherapeutic strategies to combat metastatic STSs. Expanded studies are needed to explore the clinical and immunologic effects of IT GLA-SE, particularly in combination with other immunotherapies.

Schlagwörter

Stichwörter der Autor:innen

Cancer vaccinationNY-ESO-1T cell clonal expansionTLR4 agonistintratumoral injection therapymetastatic leiomyosarcomatumor microenvironment

Autor:innen und Institutionen

  • Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
  • Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
  • Department of Medicine, City of Hope Cancer Center, Los Angeles, CA, United States.
  • Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
  • Sarcoma Center, Dana Farber Cancer Institute, Boston, MA, United States.
  • Department of Surgery, University of Washington, Seattle, WA, United States.

Zitieren

APA

Zhang, J. S., Ng, J. C. K., Hermida de Viveiros, P., Al-Marayaty, R., Al Akoum, N., Shinglot, H., Jing, W., Vizcaino, V., Alexiev, B. A., Cranmer, L. D., Loggers, E. T., Abrams, H., Wagner, M. J., Pillarisetty, V. G., Kim, E. Y., Pierce, R. H., Berglund, P., Jones, R. L., Lu, H., …, & Seo, Y. D. (2026). Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1829331

Vancouver

Zhang JS, Ng JCK, Hermida de Viveiros P, Al-Marayaty R, Al Akoum N, Shinglot H, et al. Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1829331

BibTeX
@article{Zhang2026,
  author = {Zhang, Jessica S and Ng, Juliana C K and Hermida de Viveiros, Pedro and Al-Marayaty, Rusul and Al Akoum, Nourhane and Shinglot, Himaly and Jing, Weiqing and Vizcaino, Valeria and Alexiev, Borislav A and Cranmer, Lee D and Loggers, Elizabeth T and Abrams, Hannah and Wagner, Michael J and Pillarisetty, Venu G and Kim, Edward Y and Pierce, Robert H and Berglund, Peter and Jones, Robin L and Lu, Hailing and Ter Meulen, Jan and Pollack, Seth M and Seo, Yongwoo David},
  title = {Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case series},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1829331}
}
Kostenlos starten →